Sam Reinhardt

The Horseracing Integrity and Safety Authority has released a request for proposals for research into whether furosemide is a performance-enhancing drug in Thoroughbred racehorses. The research is required as part of HISA's Congressional mandate and its conclusions will be used to guide HISA's Furosemide Advisory Committee in its recommendations to the HISA Board on next steps regarding the regulation of furosemide. Responses to the RFP are due by Oct. 15 at 11:59 p.m. ET. Questions about the RFP and the process for submitting a response may be sent to Dr....

The Horseracing Integrity and Safety Authority (HISA) has established a Next Generation Advisory Group, which will provide feedback to HISA's executive team and standing committees on the implementation and evolution of HISA's regulations and protocols. Made up of individuals in the early to mid-stages of their professional careers, the Advisory Group is open to new applicants, who can apply to join prior to the Feb. 9 deadline. "Establishing a Next Generation Advisory Group was an easy decision for HISA," said HISA CEO Lisa Lazarus. "We are safeguarding racing for generations...

HISA released a request for proposals concerning research over the administration of furosemide to Thoroughbred racehorses during the 48-hour period before the start of a race, the organization said in a release late Tuesday. This research is required as part of HISA's Congressional mandate. The conclusions will be used to guide HISA's Furosemide Advisory Committee in its recommendations to their Board on the next course of action regarding the administration of the drug. Responses are due by Nov. 15 at 11:59 pm (ET). Questions pertaining to the process for submitting...